MedTrace Logo

The Relationship Between COVID-19 and Autoimmune Diseases, Lessons From Practice

NCT04558203 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10510

Last updated 2025-04-17

No results posted yet for this study

Summary

The study explore the relationship between COVID-19 and the induction of autoimmune diseases.

This study comprises both retrospective and prospective components. The retrospective arm (2016-2019) was conducted to establish baseline incidence rates of autoimmune diseases (AIDs) prior to the COVID-19 pandemic. The prospective arm (2020-2024) involves the identification and longitudinal follow-up of newly diagnosed AID cases to evaluate disease progression, therapeutic response, and recurrence. Based on these data, the study will yield four distinct analyses:

1. trends in AID incidence before and after the COVID-19 pandemic,
2. the demographic and clinical profile of AID patients in the post-COVID-19 era,
3. the association between COVID-19 vaccine status and the development of AIDs, and
4. the clinical course, response to therapy, and long-term outcomes of AIDs in post-COVID patients compared to pre-pandemic cases.

Conditions

  • Covid19

Sponsors & Collaborators

  • ClinAmygate

    lead OTHER

Principal Investigators

  • Emad R Issak, MD · Asalam Center

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-22
Primary Completion
2025-01-05
Completion
2025-03-05

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04558203 on ClinicalTrials.gov